amiodaronklorid hameln 50 mg/ml koncentrat za otopinu za injekciju/infuziju
hameln pharma gmbh, inselstrasse 1, hameln, njemačka - amiodaronklorid - koncentrat za otopinu za injekciju / infuziju - 50 mg/ml - urbroj: 1 ml koncentrata za otopinu za injekciju/infuziju sadrži 50 mg amiodaronklorida što odgovara 46,9 mg amiodarona
pradaxa 150 mg/1 kapsula kapsula, tvrda
boehringer ingelheim bh d.o.o. - дабигатран eteksilat - kapsula, tvrda - 150 mg/1 kapsula - 1 kapsula, tvrda sadrži: 150 mg dabigatran eteksilata
pradaxa 150 mg/1 kapsula kapsula, tvrda
boehringer ingelheim bh d.o.o. - дабигатран eteksilat - kapsula, tvrda - 150 mg/1 kapsula - 1 kapsula, tvrda sadrži: 150 mg dabigatran eteksilata
sanval 5mg film tableta
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-cetinje - zolpidem - film tableta - 5mg
sanval 10mg film tableta
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-cetinje - zolpidem - film tableta - 10mg
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimikotika za sustavnu uporabu - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.
crixivan
merck sharp & dohme b.v. - индинавира sulfat ethanolate - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - crixivan je indiciran u kombinaciji s antiretrovirusnim nukleozidnim analogom za liječenje hiv-1 inficiranih odraslih osoba.
parietene macroporous mesh
druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - neaktivna implantabilna medicinska sredstva
parietene macroporous mesh
druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - implantabilna protetska i medicinska sredstva za osteosintezu
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).